Novel drug-drug salts of enoxacin with enhanced antibacterial activity: Insights from solubility and lipid-water partition coefficient
暂无分享,去创建一个
[1] Zhengzheng Zhou,et al. Two Polymorphic Cocrystals of Theophylline with Ferulic Acid , 2023, Crystal Growth & Design.
[2] Yang Lu,et al. The enhanced pH-dependent solubility behavior of three novel lamotrigine-acid salts , 2023, Journal of Molecular Liquids.
[3] Yang Lu,et al. Discovered Two Polymorphs and Two Solvates of Lamotrigine-Tolfenamic acid Salt: Thermal Behavior and Crystal Morphological Differences. , 2022, International journal of pharmaceutics.
[4] Jianting Li,et al. Structural landscape investigations on bendable plastic crystals of isonicotinamide polymorphs , 2022, Chinese Chemical Letters.
[5] Z. Min,et al. The antibacterial mechanism of perilla rosmarinic acid. , 2021, Biotechnology and applied biochemistry.
[6] Ilma Nugrahani,et al. Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development , 2021, Molecules.
[7] Dandan Huang,et al. Phase solubility investigation and theoretical calculations on drug-drug cocrystals of carbamazepine with Emodin, Paeonol , 2021 .
[8] Y. Azim,et al. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs. , 2021, RSC medicinal chemistry.
[9] T. Lu,et al. Temozolomide–Hesperetin Drug–Drug Cocrystal with Optimized Performance in Stability, Dissolution, and Tabletability , 2021 .
[10] M. K. Rana,et al. Computer-aided discovery of bis-indole derivatives as multi-target drugs against cancer and bacterial infections: DFT, docking, virtual screening, and molecular dynamics studies , 2020 .
[11] Sonali S. Bharate. Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019. , 2020, Drug discovery today.
[12] Yun-jie Zhang,et al. Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] C. Iglesia,et al. Therapeutic Suggestion in Postoperative Pain Control: A Randomized Controlled Trial , 2020, Female pelvic medicine & reconstructive surgery.
[14] Yan-Tuan Li,et al. A crystalline solid adduct of sulfathiazole–amantadine: the first dual-drug molecular salt containing both antiviral and antibacterial ingredients , 2020, CrystEngComm.
[15] N. Asfandiyarova,et al. [The use of nonsteroidal anti - inflammatory drugs in polymorbid pathology]. , 2020, Terapevticheskii arkhiv.
[16] B. Bhattacharya,et al. Screening, crystal structures and solubility studies of a series of multidrug salt hydrates and cocrystals of fenamic acids with trimethoprim and sulfamethazine , 2020 .
[17] Hailu Zhang,et al. Crystal Structures, Dissolution and Pharmacokinetic Study on a Novel Phosphodiesterase-4 Inhibitor Chlorbipram Cocrystals. , 2019, International journal of pharmaceutics.
[18] H. Tong,et al. Structure determination and in vitro/vivo study on carbamazepine-naringenin (1:1) cocrystal , 2019 .
[19] H. Tong,et al. X-ray Diffraction and Theoretical Calculation-Supported Formation of Polymorphic Cocrystals Discovered Through Thermal Methods: A Case Study. , 2019, Journal of pharmaceutical sciences.
[20] J. Gong,et al. Drug–drug salts of mefenamic acid\tolfenamic acid and piperazine to improve physicochemical properties for potential veterinary use , 2019, CrystEngComm.
[21] Panos Macheras,et al. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines. , 2019, International journal of pharmaceutics.
[22] Ana R. Jesus,et al. Enhancement of water solubility of poorly water‐soluble drugs by new biocompatible N‐acetyl amino acid N‐alkyl cholinium‐based ionic liquids , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] N. Jetté,et al. Preoperative predictors of poor acute postoperative pain control: a systematic review and meta-analysis , 2019, BMJ Open.
[24] Changquan Calvin Sun,et al. Spherical Cocrystallization—An Enabling Technology for the Development of High Dose Direct Compression Tablets of Poorly Soluble Drugs , 2019, Crystal Growth & Design.
[25] A. Mondal,et al. Multidrug salt forms of norfloxacin with non-steroidal anti-inflammatory drugs: solubility and membrane permeability studies , 2018 .
[26] Ranjit Thakuria,et al. Drug‑Drug and Drug‑Nutraceutical Cocrystal/Salt as Alternative Medicine for Combination Therapy: A Crystal Engineering Approach , 2018 .
[27] Naír Rodríguez-Hornedo,et al. Multidrug Cocrystal of Anticonvulsants: Influence of Strong Intermolecular Interactions on Physiochemical Properties. , 2017, Crystal growth & design.
[28] Ranjit Thakuria,et al. Crystal structure landscape of ethenzamide: a physicochemical property study , 2017 .
[29] N. Abell,et al. Click Quantitative Mass Spectrometry Identifies PIWIL3 as a Mechanistic Target of RNA Interference Activator Enoxacin in Cancer Cells. , 2017, Journal of the American Chemical Society.
[30] G. Desiraju,et al. A Drug-Drug Salt Hydrate of Norfloxacin and Sulfathiazole: Enhancement of in Vitro Biological Properties via Improved Physicochemical Properties. , 2016, Molecular pharmaceutics.
[31] Ke Wang,et al. Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions. , 2016, Molecular pharmaceutics.
[32] Steven A. Ross,et al. Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies. , 2016, Chemical communications.
[33] N. Rodríguez-Hornedo,et al. How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability. , 2016, Chemical communications.
[34] R. Tan,et al. Novel solid forms of oxaprozin: cocrystals and an extended release drug–drug salt of salbutamol , 2016 .
[35] Dinesh Kumar,et al. Multidrug co-crystals: towards the development of effective therapeutic hybrids. , 2016, Drug discovery today.
[36] M. Zaworotko,et al. Pharmaceutical cocrystals: along the path to improved medicines. , 2016, Chemical communications.
[37] H. Sung,et al. Identification of New Cocrystal Systems with Stoichiometric Diversity of Salicylic Acid Using Thermal Methods , 2016, Pharmaceutical Research.
[38] K. Tam,et al. pKa values in solubility determination using the Henderson-Hasselbalch equation , 2015 .
[39] G. Desiraju,et al. Tuning mechanical properties of pharmaceutical crystals with multicomponent crystals: voriconazole as a case study. , 2015, Molecular pharmaceutics.
[40] G. Sheldrick. SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.
[41] A. P. Voronin,et al. Pharmaceutical cocrystals of diflunisal and diclofenac with theophylline. , 2014, Molecular pharmaceutics.
[42] R. Tan,et al. Cocrystallization with flufenamic acid: comparison of physicochemical properties of two pharmaceutical cocrystals , 2014 .
[43] C. Cellini,et al. Postoperative Pain Control , 2013, Clinics in Colon and Rectal Surgery.
[44] A. Healy,et al. Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid. , 2013, Molecular pharmaceutics.
[45] A. Choudhury,et al. Structural Landscape of Pure Enrofloxacin and Its Novel Salts: Enhanced Solubility for Better Pharmaceutical Applicability , 2013 .
[46] N. Rodríguez-Hornedo,et al. Tailoring aqueous solubility of a highly soluble compound via cocrystallization: effect of coformer ionization, pHmax and solute–solvent interactions , 2012 .
[47] Gargi Mukherjee,et al. Polymorphs, Salts, and Cocrystals: What’s in a Name? , 2012 .
[48] J. Comer,et al. Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship. , 2010, Analytica chimica acta.
[49] Zhaoxin Lu,et al. Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. , 2009, International journal of food microbiology.
[50] Pui Shan Chow,et al. Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs , 2009 .
[51] N. Sultana,et al. Synthesis, Characterization, Antibacterial and Anti-Inflammatory Activities of Enoxacin Metal Complexes , 2009, Bioinorganic chemistry and applications.
[52] Naír Rodríguez-Hornedo,et al. Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility , 2009 .
[53] Richard J. Gildea,et al. OLEX2: a complete structure solution, refinement and analysis program , 2009 .
[54] N. Rodríguez-Hornedo,et al. Cocrystals and Salts of Gabapentin: pH Dependent Cocrystal Stability and Solubility , 2009 .
[55] A. Avdeef. Solubility of sparingly-soluble ionizable drugs. , 2007, Advanced drug delivery reviews.
[56] Christer B Aakeröy,et al. Cocrystal or salt: does it really matter? , 2007, Molecular pharmaceutics.
[57] Dan Boström,et al. Pharmaceutical Cocrystal and Salts of Norfloxacin , 2006 .
[58] A. Berthod,et al. Determination of liquid-liquid partition coefficients by separation methods. , 2004, Journal of chromatography. A.
[59] Billie Yan Zhang Hiew,et al. Adsorptive decontamination of diclofenac by three‐dimensional graphene‐based adsorbent: Response surface methodology, adsorption equilibrium, kinetic and thermodynamic studies , 2019, Environmental research.
[60] U. Domańska,et al. Study of pH-dependent drugs solubility in water , 2014 .
[61] G. Borodi,et al. Structural characterization of ambazone salt with niflumic acid , 2012 .
[62] M. Wood. Tissue Penetration and Clinical Efficacy of Enoxacin in Respiratory Tract Infections , 1989, Clinical pharmacokinetics.